Glutamate Excitotoxicity and Astrocytic Dysfunction in ALS

Glutamate-induced excitotoxicity is one of the most widely established pathogenetic mechanisms underlying selective motor neuron degeneration in ALS. Disruption of extracellular glutamate regulation triggers a fatal influx of intracellular calcium, promoting metabolic collapse.

Mechanism of Glutamate Excitotoxicity

Glutamate serves as the primary excitatory neurotransmitter in the central nervous system. In ALS, impaired synaptic clearing leads to elevated glutamate concentrations in both serum and cerebrospinal fluid (CSF):

      Presynaptic Neuron
            │ (Release of Glutamate)
            ▼
 ┌──────────────────────┐      Loss of EAAT2 Transporter
 │  Synaptic Cleft      │ ◄───────────────────────────────── Astrocytes
 └──────────┬───────────┘
            │ Excess Glutamate overstimulates AMPA receptors
            ▼
    Postsynaptic Motor Neuron
            │
            ├─► Massively Increased Intracellular Calcium [Ca2+]i
            ├─► Severe Mitochondrial Damage
            └─► Neuronal Death

Vulnerability Factors of Motor Neurons

Motor neurons are uniquely susceptible to excitotoxic injury due to several key intracellular characteristics:

1. Low Calcium Buffering Capacity: Motor neurons have low levels of intracellular calcium-binding proteins (e.g., parvalbumin, calbindin).

2. High Energy Requirement: Maintaining membrane potentials over long axonal lengths creates high metabolic demands.

3. High Neurofilament Content: Abundant neurofilaments are vulnerable to oxidative cross-linking and transport failure.

Astrocytic Glial Transporter Loss

Excitotoxicity highlights the critical role of surrounding non-neuronal cells. Astrocytes normally express Excitatory Amino Acid Transporter 2 (EAAT2), which clears excess synaptic glutamate. In ALS, local loss of astrocytic EAAT2 expression permits extracellular glutamate accumulation, driving toxic calcium influx.

Key Takeaways

• Excitotoxicity results from elevated synaptic glutamate due to loss of astrocytic EAAT2 transporters.

• Excess calcium influx combined with low endogenous calcium buffering capacity causes motor neuron death.

• Targeted anti-excitotoxic pharmacotherapy (e.g., Riluzole) remains a primary therapeutic strategy.